Literature DB >> 8735437

Rating child psychiatric caseness from detailed case histories.

R Goodman1, C Yude, H Richards, E Taylor.   

Abstract

Novel operationalized criteria were used to rate detailed psychiatric case histories on 151 schoolchildren with hemiplegia. Ratings of psychiatric caseness or non-caseness were reliable and valid; the method may be widely applicable. Caseness was defined both narrowly (in terms of social incapacity for the child) and broadly (in terms of disruption to others and distress too). Both definitions could be applied reliably to children of normal intelligence but broadly defined caseness was more reliable for children with low intelligence. Barely half of the psychiatric cases met operationalized criteria for one or more DSM-IV or ICD-10 diagnosis. The others mostly had partial or mixed syndromes that could, with clinical judgement, be assigned to "not otherwise specified' diagnoses. Even with clinical judgement, however, a substantial minority of children with low intelligence had clinically significant but undiagnosable abnormalities in social relatedness.

Entities:  

Mesh:

Year:  1996        PMID: 8735437     DOI: 10.1111/j.1469-7610.1996.tb01418.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  9 in total

1.  The Italian preadolescent mental health project (PrISMA): rationale and methods.

Authors:  Alessandra Frigerio; Laura Vanzin; Valentina Pastore; Maria Nobile; Roberto Giorda; Cecilia Marino; Massimo Molteni; Paola Rucci; Massimo Ammaniti; Loredana Lucarelli; Carlo Lenti; Mauro Walder; Andrea Martinuzzi; Ombretta Carlet; Filippo Muratori; Annarita Milone; Alessandro Zuddas; Pina Cavolina; Franco Nardocci; Andrea Tullini; Pierluigi Morosini; Gabriella Polidori; Giovanni De Girolamo
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

2.  The 'DAWBA bands' as an ordered-categorical measure of child mental health: description and validation in British and Norwegian samples.

Authors:  Anna Goodman; Einar Heiervang; Stephan Collishaw; Robert Goodman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-04-09       Impact factor: 4.328

3.  Schizophrenia with onset before the age of eleven: clinical characteristics of onset and course.

Authors:  C Eggers; D Bunk; D Krause
Journal:  J Autism Dev Disord       Date:  2000-02

4.  The Ilha de Maré study: a survey of child mental health problems in a predominantly African-Brazilian rural community.

Authors:  R Goodman; D Neves dos Santos; A P Robatto Nunes; D Pereira de Miranda; B Fleitlich-Bilyk; N Almeida Filho
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-01       Impact factor: 4.328

5.  Online child and adolescent mental health surveys can be good enough.

Authors:  Robert Goodman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-02-02       Impact factor: 4.328

6.  Psychiatric problems in children with hemiplegia: cross sectional epidemiological survey.

Authors:  R Goodman; P Graham
Journal:  BMJ       Date:  1996-04-27

7.  Cross-national differences in questionnaires do not necessarily reflect comparable differences in disorder prevalence.

Authors:  Anna Goodman; Einar Heiervang; Bacy Fleitlich-Bilyk; Abdulla Alyahri; Vikram Patel; Mohammad S I Mullick; Helena Slobodskaya; Darci Neves Dos Santos; Robert Goodman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-10-28       Impact factor: 4.328

8.  Socioeconomic Associations with ADHD: Findings from a Mediation Analysis.

Authors:  Abigail Emma Russell; Tamsin Ford; Ginny Russell
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

9.  Association between parent-infant interactions in infancy and disruptive behaviour disorders at age seven: a nested, case-control ALSPAC study.

Authors:  Christine Puckering; Clare S Allely; Orla Doolin; David Purves; Alex McConnachie; Paul C D Johnson; Helen Marwick; Jon Heron; Jean Golding; Christopher Gillberg; Philip Wilson
Journal:  BMC Pediatr       Date:  2014-09-06       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.